Results 91 to 100 of about 24,959 (193)

TNM staging of esophageal cancer using fine-tuned pathology foundation models and multiple instance learning. [PDF]

Front Oncol
Cao J, Wang J.
europepmc   +1 more source

ADAMDEC1-driven CCL2-CCR2-PD-1 axis in esophageal squamous cell carcinoma: a dual threat of O-GlcNAcylation and m⁶A methylation in neoadjuvant therapy resistance and immune evasion. [PDF]

Cell Oncol (Dordr)
Cheng J, Ma H, Qian X, Xing W.
europepmc   +1 more source

ESCA and Auger Spectroscopy [PDF]

Chemical & Engineering News Archive, 1979
openaire   +1 more source

Integrative Multi-Omics and Pan-Cancer Analyses Identify CCL20 as a Prognostic Biomarker with Therapeutic Relevance in Esophageal Cancer. [PDF]

Biomedicines
Guo S, Chen X, Wei M, Yang F, Jiang S, Zhao L, Hu L, Li Z, Shen X.   +8 more
europepmc   +1 more source

Microprobe ESCA.

Hyomen Kagaku, 1994
openaire   +2 more sources

Unveiling the role of ANGPT2 in esophageal cancer: A prognostic factor and potential oncogene. [PDF]

Oncol Rep
Zhai Z, Xue Z, Fang Y, Fan Y, Li S, Yu Y, Chen C, Zhang K, Chen D, Tang X, Ling R.   +10 more
europepmc   +1 more source

Correction: SPDL1 overexpression is associated with the 18F-FDG PET/CT metabolic parameters, prognosis, and progression of esophageal cancer. [PDF]

Front Genet
Liu HS, Guo Q, Yang H, Zeng M, Xu LQ, Zhang QX, Liu H, Guo JL, Zhang J.   +8 more
europepmc   +1 more source

Prognostic alternative splicing signatures in esophageal cancer reveal SF3A3 as a key oncogenic splicing factor. [PDF]

Transl Cancer Res
Mo J, Zou Y, Zhang J, Miao H, Chen D.
europepmc   +1 more source

Beyond Koch's postulates: the pathobiome paradigm in grapevine esca disease. [PDF]

FEMS Microbiol Ecol
Gramaje D, Eichmeier A.
europepmc   +1 more source

Prognostic biomarkers related to PANoptosis in esophageal cancer and their immune microenvironment: multi-omics analysis and therapeutic significance. [PDF]

Front Oncol
Jie R, Liu Y, Wang T, Wusiman S, Ren H, Tuoheniyazi W, Liu L.   +6 more
europepmc   +1 more source